Search results
Pfizer (NYSE:PFE) Shares Up 2%
ETF DAILY NEWS· 8 hours agoPfizer Inc. (NYSE:PFE – Get Free Report)’s share price was up 2% during trading on Wednesday . The stock traded as high as $29.18 and ...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 1 day agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 6 hours agoNot only has it recently been trading at attractive levels, it's also currently sporting a fat...
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 1 day agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Zacks via Yahoo Finance· 1 day agoThis is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first...
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
The Motley Fool via AOL· 3 days agoPfizer stock lost nearly half its value over the past couple of years, but some of the world's most successful investors bought millions of shares in the first quarter.
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 4 days agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average
Zacks via Yahoo Finance· 1 day agoFrom a technical perspective, Pfizer (PFE) is looking like an interesting pick, as it just reached a...
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 4 days agoArgus downgraded its Pfizer Inc. [PFE] rating to a Hold from a a Buy in a research...revised their coverage, including Guggenheim’s analysts, who began to cover the
Is Pfizer Finally Seeing Light at the End of the Tunnel?
TheStreet.com· 1 day agoPharmaceutical giant Pfizer (PFE) has been a weak performer in the stock market. The shares are...